Polypodium Leucotomos - An Overview of Basic Investigative Findings

February 2016 | Volume 15 | Issue 2 | Original Article | 224 | Copyright © 2016

Brian Berman MD PhD,a,b Charles Ellis MD,c and Craig Elmets MDd,*

aCenter for Clinical and Cosmetic Research, Aventura, FL
bEmeritus Professor of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine,Miami, FL
cUniversity of Michigan Medical School, Ann Arbor, MI
dUniversity of Alabama at Birmingham, Birmingham, AL
*Supported by NIH Grant AR050948

Abstract

The use of Polypodium leucotomos, a species of fern, has been reported to be beneficial in the treatment of atopic dermatitis, vitiligo, and psoriasis, and for prevention of polymorphic light eruption, sunburn, and squamous cell carcinoma. We review the in vivo animal, in vitro human, and human clinical studies performed to help elucidate the actions of and biologic pathways affected by P. leucotomos. These results serve as the scientific rationale and basis for the protection and effectiveness afforded by P. leucotomos in cutaneous diseases.

J Drugs Dermatol. 2016;15(2):224-228.

Purchase Original Article

Purchase a single fully formatted PDF of the original manuscript as it was published in the JDD.

Download the original manuscript as it was published in the JDD.

Contact a member of the JDD Sales Team to request a quote or purchase bulk reprints, e-prints or international translation requests.

To get access to JDD's full-text articles and archives, upgrade here.

Save an unformatted copy of this article for on-screen viewing.

Print the full-text of article as it appears on the JDD site.

→ proceed | ↑ close

INTRODUCTION

Polypodium leucotomos is a species of fern in the family Polypodiaceae. The South American P. leucotomos species is known locally as “calaguala” and extracts of this fern are called “anapsos.” P. leucotomos extracts have been used for the treatment of psoriasis in South America and Spain1 and growing clinical scientific evidence suggests P. leucotomos is also beneficial for the treatment of various skin disorders and conditions including atopic dermatitis,2 vitiligo3 and, because it affords sun protection from ultraviolet radiation, prevention of polymorphic light eruption.4 Its antitumor effects were alluded to nearly 50 years ago.5 Phenolic components of P. leucotomos extract include chlorogenic acid, coumaric acid, vanillic acid, caffeic acid and ferulic acid, the latter two being the most potent inhibitors of oxidation in vitro.6,7 We review the in vivo animal, in vitro human, and human clinical studies performed to help elucidate the actions of and pathways affected by PL.

EXPERIMENTAL EVIDENCE

In Vivo Animal Studies

Strains of hairless albino mice have been developed for studying the harmful effects of UV radiation on the skin8,9; using these animals, numerous studies have demonstrated the beneficial effects of P. leucotomos following skin exposure to ultraviolet light.

In 1999, the antioxidant and photoprotective properties of P. leucotomos extract were demonstrated when applied topically to hairless mice exposed to UVB radiation.10 Compared to untreated mice, P. leucotomos-treated mice showed a significant reduction in the sunburn response and diminished histologic evidence of photoaging damage, including reduced dermal elastosis. Eight weeks after stopping UV exposure, P. leucotomos-treated mice also showed a reduction in the development of skin tumors compared to untreated UV-exposed mice.

A subsequent study showed that P. leucotomos also has beneficial effects when administered orally in a similar hairless mouse model.11 These animals were fed ~300mg/kg/day of P. leucotomos extract or vehicle in their drinking water for 10 days and then exposed to UV radiation and evaluated for cyclooxygenase-2 (Cox-2) expression by Western blot analysis. Upregulation of Cox-2 is associated with UV-induced skin cancer.12,13 Cox-2 levels were 4-times lower in P. leucotomos-fed mice at 48 hours and 5-times lower at 72 hours, compared to vehicle fed mice. Other beneficial effects of feeding P. leucotomos included a significant decrease in UV-induced inflammation including a 60% decrease in neutrophil infiltration into the skin at 24 hours and a 50% decrease macrophages in the skin at 24 and 48 hours.11

Other studies have assessed the ability of P. leucotomos to counteract UV radiation-associated skin cancers. In one study, animals received an oral extract of P. leucotomos (~300 mg/kg) for 5 days prior to UVB (equivalent to 1-1.5 times the minimal erythema dose [MED] and for 2 days afterward. The number of cells positive for the tumor suppressor p53 increased by 63%, proliferating cells decreased by 13% in P. leucotomos treated mice compared to mice that were UV-irradiated but did not receive P. leucotomos. They also had a reinforced network of dermal elastic fibers.14 These animals were observed to have an enhanced the antioxidant plasma capacity that was 30% greater

↑ back to top


Related Articles